Abrysvo Dosage
Generic name: RECOMBINANT STABILIZED RSV A PREFUSION F ANTIGEN 0.06mg in 0.5mL, RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN 0.06mg in 0.5mL;
Dosage form: injection
Drug class: Viral vaccines
Medically reviewed by Drugs.com. Last updated on Jan 10, 2025.
Dose and Schedule
After reconstitution, a single dose of ABRYSVO is either 0.5 mL (Act-O-Vial presentation and vial and vial presentation) or approximately 0.5 mL (vial and prefilled syringe presentation).
Presentations and Reconstitution
ABRYSVO is supplied in 3 presentations as follows:
Act-O-Vial Presentation
The Act-O-Vial presentation is supplied in cartons. Each Act-O-Vial contains the Lyophilized Antigen Component (a sterile white powder) and Sterile Water Diluent Component.
Vial and Prefilled Syringe Presentation
The vial and prefilled syringe presentation is supplied in cartons containing a kit(s). Each kit includes a vial of Lyophilized Antigen Component (a sterile white powder), a prefilled syringe containing Sterile Water Diluent Component, and a vial adapter.
Vial and Vial Presentation
The vial and vial presentation is supplied in cartons that include vials of Lyophilized Antigen Component (a sterile white powder) and vials containing Sterile Water Diluent Component.
For all presentations, reconstitute the Lyophilized Antigen Component with the Sterile Water Diluent Component to form ABRYSVO, as described in the instructions below.
Reconstitution Instructions for the Act-O-Vial Presentation
Reconstitution Instructions for Vial and Prefilled Syringe Presentation
Reconstitution Instructions for the Vial and Vial Presentation
Administration
For intramuscular injection
After reconstitution, ABRYSVO is a clear and colorless solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Discard if either condition is present.
Administer ABRYSVO immediately or store at room temperature [15°C to 30°C (59°F to 86°F)] and use within 4 hours. Discard reconstituted vaccine if not used within 4 hours.
Frequently asked questions
- What is the difference between Arexvy and Abrysvo?
- What are the symptoms of RSV(respiratory syncytial virus)
More about Abrysvo (rsv vaccine, pref a-pref b, recombinant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Arexvy
Arexvy is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Beyfortus
Beyfortus is used to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
mRESVIA
mRESVIA is a vaccine used to immunize adults aged 60 years and older against lower respiratory ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
Enflonsia
Enflonsia is an FDA-approved medication used to prevent respiratory syncytial virus (RSV) lower ...
Rsv vaccine pref3, recombinant
Rsv vaccine pref3, recombinant is used for RSV, RSV Vaccination and Immunization
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.